Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (17)

  1. Serge Perrot, Anne-Priscille Trouvin. Cannabis for musculoskeletal pain and arthritis: Evidence is needed. Joint Bone Spine 2019;86:1
    https://doi.org/10.1016/j.jbspin.2018.03.004
  2. Nathan Herrmann, Myuri Ruthirakuhan, Damien Gallagher, Nicolaas Paul L.G. Verhoeff, Alex Kiss, Sandra E. Black, Krista L. Lanctôt. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry 2019;27:1161
    https://doi.org/10.1016/j.jagp.2019.05.002
  3. Douglas E. Brenneman, Dean Petkanas, William A. Kinney. Pharmacological Comparisons Between Cannabidiol and KLS-13019. J Mol Neurosci 2018;66:121
    https://doi.org/10.1007/s12031-018-1154-7
  4. Andrea Mastinu, Marika Premoli, Giulia Ferrari-Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo, Sara Anna Bonini. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. 2018;36
    https://doi.org/10.1515/hmbci-2018-0013
  5. Sara Anna Bonini, Marika Premoli, Simone Tambaro, Amit Kumar, Giuseppina Maccarinelli, Maurizio Memo, Andrea Mastinu. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology 2018;227:300
    https://doi.org/10.1016/j.jep.2018.09.004
  6. Per Damkier, Dorte Lassen, Mette Marie Hougaard Christensen, Kenneth Grønkjaer Madsen, Maja Hellfritzsch, Anton Pottegård. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol 2019;124:28
    https://doi.org/10.1111/bcpt.13152
  7. Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam, Victor Novack. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 2018;49:44
    https://doi.org/10.1016/j.ejim.2018.01.019
  8. Amir Minerbi, Winfried Häuser, Mary-Ann Fitzcharles. Medical Cannabis for Older Patients. Drugs Aging 2019;36:39
    https://doi.org/10.1007/s40266-018-0616-5
  9. Anthony M. Downs, Kaitlyn M. Roman, Simone A. Campbell, Antonio Pisani, Ellen J. Hess, Paola Bonsi. The neurobiological basis for novel experimental therapeutics in dystonia. Neurobiology of Disease 2019;130:104526
    https://doi.org/10.1016/j.nbd.2019.104526
  10. Sarah Pirio Richardson, H. A. Jinnah. New approaches to discovering drugs that treat dystonia. Expert Opinion on Drug Discovery 2019;14:893
    https://doi.org/10.1080/17460441.2019.1623785
  11. . Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited. Drugs Ther Perspect 2019;35:486
    https://doi.org/10.1007/s40267-019-00658-0
  12. Serge Perrot, Anne-Priscille Trouvin. Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires. Revue du Rhumatisme 2019;86:215
    https://doi.org/10.1016/j.rhum.2019.03.009
  13. Douglas E. Brenneman, William A. Kinney, Sara Jane Ward. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity. J Mol Neurosci 2019;68:603
    https://doi.org/10.1007/s12031-019-01321-z
  14. A.-P. Trouvin, S. Perrot. Cannabis : enjeux et risques en médecine de la douleur. Douleur analg 2019;32:73
    https://doi.org/10.3166/dea-2019-0062
  15. Renata Rizzo, Mariangela Gulisano. Treatment Resistance in Psychiatry. 2019.
    https://doi.org/10.1007/978-981-10-4358-1_16
  16. Hillary D. Lum, Kanika Arora, J. Alton Croker, Sara H. Qualls, Melissa Schuchman, Julie Bobitt, Gary Milavetz, Brian Kaskie. Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans. Gerontology and Geriatric Medicine 2019;5:233372141984370
    https://doi.org/10.1177/2333721419843707
  17. Jodie Belinda Hillen, Natalie Soulsby, Chris Alderman, Gillian E. Caughey. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic Advances in Drug Safety 2019;10:204209861984699
    https://doi.org/10.1177/2042098619846993